<unk>  is an orally effective NSAID that has antipyretic actions. It was developed by  McNeil Pharmaceutical and approved by the FDA in 1980 and sold as the sodium salt,<unk>  sodium, under the brand name Zomax.  Due to its clinical effectiveness, it was preferred by doctors in many situations and obtained a large share of the analgesics market;  however, it was subsequently withdrawn in March 1983 due to its tendency to cause serious anaphylaxis in an unpredictable subset of the patient population.
Zomepirac
Clebopride
Prucalopride
Bromopride
Sultopride
Domiphen
Tasimelteon
Ipecacuanha